MARKET

PRPH

PRPH

Prophase Lab
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.53
-0.07
-1.25%
Closed 16:00 05/07 EDT
OPEN
5.68
PREV CLOSE
5.60
HIGH
5.77
LOW
5.45
VOLUME
50.67K
TURNOVER
--
52 WEEK HIGH
16.04
52 WEEK LOW
1.200
MARKET CAP
83.80M
P/E (TTM)
-27.5673
1D
5D
1M
3M
1Y
5Y
ProPhase Labs partners with Dutchess County New York to provide COVID-19 testing
ProPhase Labs (PRPH) has signed a contract with Dutchess County, New York to provide COVID-19 testing.Dutchess County Government will offer ProPhase Lab’s saliva-based, viral RT-PCR multiplex-testing which can quickly detect COVID-19 and
Seekingalpha · 2d ago
ProPhase Labs Reports Partnership With Dutchess County New York To Provide COVID-19 Testing, No Terms Disclosed
ProPhase Labs, Inc. (NASDAQ:PRPH), a diversified medical science and technology company, today announced that it has signed a contract with Dutchess County, New York to provide reliable COVID-19 testing to its nearly
Benzinga · 2d ago
BRIEF-ProPhase Labs Inc To Provide Covid-19 Testing For Oyster Bay Township In New York
reuters.com · 04/22 12:44
Oral Spray Market Insights, Size, Share 2021 Globally Industry Demand, Growing At A CAGR of 1.6 %, Trends Evaluation, Regional Overview, Top Key Players, Business Growth Rate and Forecast to 2027
Apr 21, 2021 (The Expresswire) -- Global “Oral Spray Market” Report analysis and insights 2021-2027 is a comprehensive analysis mainly on in-depth research...
The Express Wire · 04/21 06:02
ProPhase Labs to Host First Quarter 2021 Financial Results Conference Call on Thursday, May 13, 2021 at 4:30 p.m. Eastern Time
GARDEN CITY, NY, April 15, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, will hold a conference call on Thursday, May 13, 2021 at 4:30 p.m. Eastern time to discuss its results for the fir...
GlobeNewswire · 04/15 12:49
Global Oral Spray Market Share 2021-2025 with Top Countries Data Industry Size, Share, Business Growth, Revenue, Trends, Market Demand Penetration and Forecast
Apr 14, 2021 (The Expresswire) -- Global “Oral Spray Market" research report 2021-2025 gives A top to bottom explanation on the key impacting factors, market...
The Express Wire · 04/14 05:01
Universe Pharmaceuticals, Applied Molecular Transport leads healthcare gainers; AzurRx BioPharma, BioXcel Therapeutics among major losers
Gainers: Universe Pharmaceuticals UPC +50%, Applied Molecular Transport AMTI +26%, Sonoma Pharmaceuticals (SNOA) +17%, United Therapeutics UTHR +16%, PAVmed (PAVM) +12%.Losers: AzurRx BioPharma (AZRX) -28%, BioXcel Therapeutics (BTAI) -14%, Emergent BioSol...
Seekingalpha · 04/01 15:04
MicroVision, Telos among premarket losers' pack
AzurRx BioPharma (AZRX) -29% after MS1819 fails in mid-stage cystic fibrosis study.XpresSpa Group (XSPA) -15% on Q4 earnings release.CTI BioPharma (CTIC) -12% after secures $51M capital raise.MicroVision (MVIS) -12%.Boston Omaha (BOMN) -10% on pricing publ...
Seekingalpha · 04/01 12:13
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PRPH. Analyze the recent business situations of Prophase Lab through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average PRPH stock price target is 22.50 with a high estimate of 25.00 and a low estimate of 20.00.
EPS
Institutional Holdings
Institutions: 27
Institutional Holdings: 740.24K
% Owned: 4.88%
Shares Outstanding: 15.15M
TypeInstitutionsShares
Increased
0
0
New
5
228.38K
Decreased
0
0
Sold Out
1
1.36K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Food Processing
-0.04%
Food & Tobacco
+0.44%
Key Executives
Chairman/Chief Executive Officer/Director
Ted Karkus
Chief Financial Officer
Monica Brady
Independent Director
Jason Barr
Independent Director
Louis Gleckel
Independent Director
Warren Hirsch
Declaration Date
Dividend Per Share
Ex-Div Date
11/20/2019
Dividend USD 0.25
12/02/2019
11/20/2019
Special Dividend USD 0.25
12/02/2019
12/26/2018
Dividend USD 0
01/09/2019
12/26/2018
Special Dividend USD 0.25
01/09/2019
05/07/2018
Dividend USD 0
06/06/2018
05/07/2018
Special Dividend USD 1
06/06/2018
  • All
  • Financials
  • Insiders
More
About PRPH
ProPhase Labs, Inc. manufactures, markets and distributes a range of homeopathic and healthcare products. The Company is engaged in the research and development of over-the-counter (OTC) drugs and natural base health products, including supplements, personal care and cosmeceutical products. The Company's products include TK Supplements and ORXx Complete. TK Supplements consists of LEGENDZ XL, a male sexual enhancement; TRIPLE EDGE XL, a daily energy and stamina booster, and SUPER PROSTAFLOW plus, a supplement to support prostate and urinary health. The Company's OTC offerings include the ORXx cough/cold drops. Its consumer health customers include national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies.

Webull offers kinds of ProPhase Labs Inc stock information, including NASDAQ:PRPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRPH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PRPH stock methods without spending real money on the virtual paper trading platform.